Porphyromonas gingivalis-impaired innate immune response via NLRP3 proteolysis in endothelial cells

Innate Immunity

Volumn 21, Issue 1, 2015, Pages 65-72

  Huck, Olivier ^a,b   Elkaim, René ^a,b   Davideau, Jean Luc ^a,b   Tenenbaum, Henri ^a,b  

^a Université de Strasbourg   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

atherosclerosis; endothelial; Inflammasome; inflammation; NLRP3; Porphyromonas gingivalis

Indexed keywords

CRYOPYRIN; CYCLOHEXIMIDE; INTERLEUKIN 1BETA; MESSENGER RNA; CARRIER PROTEIN; INFLAMMASOME; LIPOPOLYSACCHARIDE; NLRP3 PROTEIN, HUMAN; PROTEIN SYNTHESIS INHIBITOR;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PORPHYROMONAS GINGIVALIS INFECTION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BACTEROIDACEAE INFECTION; BIOSYNTHESIS; CELL CULTURE; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

PORPHYROMONAS GINGIVALIS;

BACTEROIDACEAE INFECTIONS; CARRIER PROTEINS; CELLS, CULTURED; CYCLOHEXIMIDE; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; PORPHYROMONAS GINGIVALIS; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84914126583     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425914523459     Document Type: Article

References (27)

1. Rosenfeld ME, Campbell LA. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost. 2011 ; 106: 858-867
2. Elkaim R, Dahan M, Kocgozlu L, et al. Prevalence of periodontal pathogens in subgingival lesions, atherosclerotic plaques and healthy blood vessels: a preliminary study. J Periodont Res. 2008 ; 43: 224-231
3. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005 ; 366: 1809-1820
4. Huck O, Saadi-Thiers K, Tenenbaum H, et al. Evaluating periodontal risk for patients at risk of or suffering from atherosclerosis: recent biological hypotheses and therapeutic consequences. Arch Cardiovasc Dis. 2011 ; 104: 352-358
5. Huck O, Elkaim R, Davideau J-L, Tenenbaum H. Porphyromonas gingivalis and its lipopolysaccharide differentially regulate the expression of cathepsin B in endothelial cells. Mol Oral Microbiol. 2012 ; 27: 1-12
6. Hajishengallis G, Sojar H, Genco RJ, DeNardin E. Intracellular signaling and cytokine induction upon interactions of Porphyromonas gingivalis fimbriae with pattern-recognition receptors. Immunol Invest. 2004 ; 33: 157-172
7. Sima AV, Stancu CS, Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res. 2009 ; 335: 191-203
8. Kocgozlu L, Elkaim R, Tenenbaum H, Werner S. Variable cell responses to P. gingivalis lipopolysaccharide. J Dent Res. 2009 ; 88: 741-745
9. Hansson GK, Klareskog L. Pulling down the plug on atherosclerosis: cooling down the inflammasome. Nat Med. 2011 ; 17: 790-791
10. Schroder K, Tschopp J. The inflammasomes. Cell. 2010 ; 140: 821-832
11. Chen G, Pedra JHF. The inflammasome in host defense. Sensors. 2010 ; 10: 97-111
12. Franchi L, Muñoz-Planillo R, Nuñez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol. 2012 ; 13: 325-332
13. Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010 ; 464: 1357-1361
14. Zheng F, Xing S, Gong Z, Xing Q. NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis. Heart Lung Circ. 2013 ; 22: 746-750
15. Yilmaz O, Sater AA, Yao L, et al. ATP-dependent activation of an inflammasome in primary gingival epithelial cells infected by Porphyromonas gingivalis. Cell Microbiol. 2010 ; 12: 188-198
16. Belibasakis GN, Guggenheim B, Bostanci N. Down-regulation of NLRP3 inflammasome in gingival fibroblasts by subgingival biofilms: Involvement of Porphyromonas gingivalis. Innate Immun. 2012 ; 19: 3-9
17. Taxman DJ, Swanson KV, Broglie PM, et al. Porphyromonas gingivalis mediates inflammasome repression in polymicrobial cultures through a novel mechanism involving reduced endocytosis. J Biol Chem. 2012 ; 287: 32791-327999
18. Elkaim R, Werner S, Kocgozlu L, Tenenbaum H. P. gingivalis regulates the expression of Cathepsin B and Cystatin C. J Dent Res. 2008 ; 87: 932-936
19. Vernal R, León R, Silva A, et al. Differential cytokine expression by human dendritic cells in response to different Porphyromonas gingivalis capsular serotypes. J Clin Periodontol. 2009 ; 36: 823-829
20. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011 ; 469: 221-225
21. Bostanci N, Emingil G, Saygan B, et al. Expression and regulation of the NALP3 inflammasome complex in periodontal diseases. Clin. Exp. Immunol. 2009 ; 157: 415-422
22. Belibasakis GN, Johansson A. Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine. 2012 ; 11: 1-7
23. Madrigal AG, Barth K, Papadopoulos G, Genco CA. Pathogen-mediated proteolysis of the cell death regulator RIPK1 and the host defense modulator RIPK2 in human aortic endothelial cells. Plos One. 2012 ; 8: e1002723 - e1002723
24. Shi C-S, Shenderov K, Huang N-N, et al. Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat. Immunol. 2012 ; 13: 255-263
25. Schildberger A, Rossmanith E, Weber V, Falkenhagen D. Monitoring of endothelial cell activation in experimental sepsis with a two-step cell culture model. Innate Immunity. 2010 ; 16: 278-287
26. Bélanger M, Rodrigues PH, Dunn WA, Progulske-Fox A. Autophagy: a highway for Porphyromonas gingivalis in endothelial cells. Autophagy. 2006 ; 2: 165-170
27. Masters SL, Latz E, O'Neill LAJ. The inflammasome in atherosclerosis and type 2 diabetes. Sci Transl Med. 2011 ; 3: 1-7